NCT04666545

Brief Summary

For patients with kidney failure the two treatment options are kidney transplantation or dialysis. Transplantation offers longer survival, better quality of life and provides cost savings for the health system (\>$60,000/year per patient). Unfortunately, there are not enough organs available and 20% of patients die on dialysis waiting for a deceased donor kidney. Living kidney donation is a safe and proven treatment that leads to even better patient and health system outcomes than deceased donor kidney transplant. The Kidney Health Strategic Clinical Network (KH-SCN) identified increasing living kidney donation as a priority and in 2015 established the Living Donor Kidney Transplant Working Group (LDKTWG) comprised of patients, donors, health care professionals, researchers, and administrators. In an evidenced review published by the investigators, the intervention with the best evidence and greatest impact was personalized support provided by a multidisciplinary team to inform and educate the patients' social network. This intervention increased living kidney donations by 34%. The investigators confirmed through a province wide survey that many patients with kidney failure are unable to find a living kidney donor and find it difficult to approach potential donors due to lack of skills, supports, and resources and these issues are particularly apparent in vulnerable populations. The investigators have developed the Multidisciplinary Support To Access living donor Kidney Transplant (MuST AKT) intervention to support patients in identifying and communicating with their social networks. The investigators will test the effectiveness of this intervention.

Trial Health

75
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
38

participants targeted

Target at P25-P50 for not_applicable

Timeline
4mo left

Started May 2021

Longer than P75 for not_applicable

Geographic Reach
1 country

1 active site

Status
active not recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress94%
May 2021Sep 2026

First Submitted

Initial submission to the registry

November 23, 2020

Completed
21 days until next milestone

First Posted

Study publicly available on registry

December 14, 2020

Completed
5 months until next milestone

Study Start

First participant enrolled

May 12, 2021

Completed
5.3 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

September 1, 2026

Expected
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

September 1, 2026

Last Updated

January 7, 2026

Status Verified

January 1, 2026

Enrollment Period

5.3 years

First QC Date

November 23, 2020

Last Update Submit

January 5, 2026

Conditions

Outcome Measures

Primary Outcomes (1)

  • Living Kidney Donor Evaluation Started

    Proportion of participants with at least one potential donor who started evaluation

    12 months

Secondary Outcomes (4)

  • Living Kidney Donor Transplantation

    24 months

  • Contact Living Donor Services

    12 months

  • Living Kidney Donor Evaluation Completed

    12 months

  • Identified potential advocates

    From date of first to last documented session, an average of 3 months

Other Outcomes (11)

  • Participant recommendation

    At date of last documented session, an average of 3 months

  • Perception of program effectiveness (1 item developed for this study)

    At date of last documented session, an average of 3 months

  • Self-efficacy for approaching a potential donor as assessed by 1 item developed for this study: "How confident are you that you can talk to a friend or family member about being a potential living kidney donor?"

    3 months (length of intervention)

  • +8 more other outcomes

Study Arms (2)

Intervention

EXPERIMENTAL

This arm will receive the MuST AKT intervention, which is a multidisciplinary, tailored person-centered behavioural intervention designed to "help and enable" the potential kidney transplant recipients to achieve what is required to receive a living donor kidney transplantation.

Behavioral: MuST AKT

Usual Care (control)

NO INTERVENTION

In the usual care (control) condition, participants will go through the current standard of care, which is a social worker assessment.

Interventions

MuST AKTBEHAVIORAL

A behavioural intervention designed to help participants identify and communicate with their social network about living kidney donation.

Intervention

Eligibility Criteria

Age18 Years - 75 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • English speaking
  • No obvious contraindication to kidney transplantation
  • Completed 'introduction to kidney transplant' module

You may not qualify if:

  • Potential Living Kidney Donor identified
  • Previously received organ transplant
  • Candidate for multi-organ transplant
  • Stanford Integrated Psychosocial Assessment for Transplant (SIPAT) Score \> 20
  • Rapid Estimate of Adult Literacy in Medicine (REALM-66) score \< 19 (illiterate in English)

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

University of Alberta Hospital

Edmonton, Alberta, Canada

Location

Related Publications (1)

  • Selzler AM, Davoodi PM, Klarenbach S, Lam NN, Smith T, Ackroyd A, Wiebe N, Corradetti B, Ferdinand S, Iyekekpolor D, Smith G, Verdin N, Bello AK, Wen K, Shojai S; Multidisciplinary Support To Access living donor Kidney Transplant (MuST AKT) Research Group. Multidisciplinary Support To Access living donor Kidney Transplant (MuST AKT): A Clinical Research Protocol for a Pilot Randomized Controlled Trial to Increase Living Kidney Donation. Can J Kidney Health Dis. 2023 Oct 30;10:20543581231205340. doi: 10.1177/20543581231205340. eCollection 2023.

Study Officials

  • Dr. Shojai

    University of Alberta

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
INVESTIGATOR
Purpose
OTHER
Intervention Model
PARALLEL
Model Details: Pilot parallel block randomized controlled trial
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

November 23, 2020

First Posted

December 14, 2020

Study Start

May 12, 2021

Primary Completion (Estimated)

September 1, 2026

Study Completion (Estimated)

September 1, 2026

Last Updated

January 7, 2026

Record last verified: 2026-01

Data Sharing

IPD Sharing
Will not share

Locations